I have been watching this small bio company for a little over a year now. They had a co-operative agreement with Abbot to develope a Lupus drug. Early results from trials looked unfavorable, and Abbot pulled out. Full results however looked promising, and the company is about to start Phase III trials. The FDA awarded them 'orphan drug status' earlier this week. The price has been creeping up last few weeks, presumably in anticipation of next trials. I know Fools are very interested in biotech and pharma, is anyone else watching LJPC?Spode
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimate